JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 90 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $132,000 | -68.0% | 19,503 | -60.5% | 0.01% | -76.0% |
Q4 2021 | $412,000 | +81.5% | 49,384 | +48.2% | 0.02% | +31.6% |
Q2 2021 | $227,000 | +34.3% | 33,322 | +37.7% | 0.02% | +5.6% |
Q4 2020 | $169,000 | -71.7% | 24,204 | -64.7% | 0.02% | -48.6% |
Q4 2019 | $598,000 | +176.9% | 68,528 | +106.4% | 0.04% | +118.8% |
Q3 2018 | $216,000 | – | 33,197 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |